Ep81: Will West, CEO of CellCentric, leaders in epigenetic cancer drug development, using genetic markers to cure cancer

HealthTech Hour di Steve Roest

S01 E83
58:50
Note sull'episodio

Will West is CEO of CellCentric speaks to Steve Roest, CEO of PocDoc this week. Will and CellCentric are using next generation epigenetic data to create cancer drugs that can stop certain types of cancer at a genetic level. Epigenetics is a hugely fascinating and slight mind-bending area of scientific development!

Parole chiave
healthbiotechdrugsblood cancergeneticsepigeneticsgene therapycambridge